3D-QSAR, molecular docking, DFT and ADMET studies on quinazoline derivatives to explore novel DHFR inhibitors

References

• BIOvIA Discovery Studio. (2015). Discovery studio modeling environment. Dassault Systemes, Release. https://doi.org/10.11436/mssj.17.98
   Google Scholar
• Clark, D. E. (2003). In silico prediction of blood–brain barrier permeation. Drug Discovery Today, 8(20), 927–933. https://doi.org/10.1016/S1359-6446(03)02827-7
   PubMed Web of Science ®Google Scholar
• Clark, M., Cramer, R. D., & Van Opdenbosch, N. (1989). Validation of the general purpose tripos 5.2 force field. Journal of Computational Chemistry, 10(8), 982–1012. https://doi.org/10.1002/jcc.540100804
   Web of Science ®Google Scholar
• Cramer, R. D., Patterson, D. E., & Bunce, J. D. (1988). Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier r proteins. Journal of the American Chemical Society, 110(18), 5959–5967. https://doi.org/10.1021/ja00226a005
   PubMed Web of Science ®Google Scholar
• Ecker, A., Lehane, A. M., & Fidock, D. A. (2011). Molecular markers of plasmodium resistance to antimalarials. In Andrea Ecker, Adele M. Lehane, and David A. Fidock (Eds.), Treatment and prevention of malaria: Antimalarial drug chemistry, action and use (pp. 249–280). https://doi.org/10.1007/978-3-0346-0480-2_13
   Google Scholar
• Ferreira, L. L. G., & Andricopulo, A. D. (2019). ADMET modeling approaches in drug discovery. Drug Discovery Today, 24(5), 1157–1165. https://doi.org/10.1016/j.drudis.2019.03.015
   PubMed Web of Science ®Google Scholar
• Fierro, A., Matthies, D. J., Cassels, B. K., Jaque, P., & Zapata-Torres, G. (2021). 5-HT2 receptor subfamily and the halogen bond promise. Journal of Chemical Information and Modeling, 61(10), 5001–5012. https://doi.org/10.1021/acs.jcim.1c00466
   PubMed Web of Science ®Google Scholar
• Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Montgomery, J. A., J., Vreven, T., Kudin, K. N., Burant, J. C., Millam, J. M., Iyengar, S. S., Tomasi, J., Barone, V., Mennucci, B., Cossi, M., Scalmani, G., Rega, G. A., Petersson, … Pople, J. A. (2004). Gaussian 03, Revision C.02. Journal of Computational Chemistry, 24(14).
   Google Scholar
• Garrido-Cardenas, J. A., González-Cerón, L., Manzano-Agugliaro, F., & Mesa-Valle, C. (2019). Plasmodium genomics: an approach for learning about and ending human malaria. Parasitology Research, 118(1), 1–27. https://doi.org/10.1007/s00436-018-6127-9
   PubMed Web of Science ®Google Scholar
• Giao, P., & De Vries, P. J. (2001). Pharmacokinetic interactions of antimalarial agents. Clinical Pharmacokinetics, 40(5), 343–373. https://doi.org/10.2165/00003088-200140050-00003
   PubMed Web of Science ®Google Scholar
• Golbraikh, A., & Tropsha, A. (2002). Beware of q2!. Journal of Molecular Graphics & Modelling, 20(4), 269–276. https://doi.org/10.1016/S1093-3263(01)00123-1
   PubMed Web of Science ®Google Scholar
• Guinovart, C., Navia, M., Tanner, M., & Alonso, P. (2006). Malaria: Burden of disease. Current Molecular Medicine, 6(2), 137–140. https://doi.org/10.2174/156652406776055131
   PubMed Web of Science ®Google Scholar
• Hadni, H., & Elhallaoui, M. (2019). Molecular docking and QSAR studies for modeling the antimalarial activity of hybrids 4-anilinoquinoline-triazines derivatives with the wild-type and mutant receptor pf-DHFR. Heliyon, 5(8), e02357. https://doi.org/10.1016/j.heliyon.2019.e02357
   PubMed Web of Science ®Google Scholar
• Hadni, h., & Elhallaoui, m. (2020). 2D and 3D-QSAR, molecular docking and ADMET properties in silico studies of azaaurones as antimalarial agents. New Journal of Chemistry, 44(16), 6553–6565. https://doi.org/10.1039/C9NJ05767F
   Web of Science ®Google Scholar
• Hadni, H., & Elhallaoui, M. (2020). 3D-QSAR, docking and ADMET properties of aurone analogues as antimalarial agents. Heliyon, 6(4), e03580. https://doi.org/10.1016/j.heliyon.2020.e03580
   PubMed Web of Science ®Google Scholar
• Hadni, H., Mazigh, M., & El Hallaoui, M. (2019). QSAR and Molecular docking studies of 4-anilinoquinoline- triazine hybrids as pf-DHFR inhibitors. Mediterranean Journal of Chemistry, 8(2), 84–93. https://doi.org/10.13171/mjc8219040407hh
   Google Scholar
• Hadni, H., Mazigh, M., Charif, E., Bouayad, A., & Elhallaoui, M. (2018). Molecular modeling of antimalarial agents by 3D-QSAR study and molecular docking of two hybrids 4-Aminoquinoline-1,3,5-triazine and 4-aminoquinoline-oxalamide derivatives with the receptor protein in its both wild and mutant types. Biochemistry Research International, 2018, 8639173–8639115. https://doi.org/10.1155/2018/8639173
   PubMed Web of Science ®Google Scholar
• Hyde, J. E. (2005). Drug-resistant malaria. Trends in Parasitology, 21(11), 494–498. https://doi.org/10.1016/j.pt.2005.08.020
   PubMed Web of Science ®Google Scholar
• Irwin, J. J., Tang, K. G., Young, J., Dandarchuluun, C., Wong, B. R., Khurelbaatar, M., Moroz, Y. S., Mayfield, J., & Sayle, R. A. (2020). ZINC20-A free ultralarge-scale chemical database for ligand discovery. Journal of Chemical Information and Modeling, 60(12), 6065–6073. https://doi.org/10.1021/acs.jcim.0c00675
   PubMed Web of Science ®Google Scholar
• Jia, C. Y., Li, J. Y., Hao, G. F., & Yang, G. F. (2020). A drug-likeness toolbox facilitates ADMET study in drug discovery. Drug Discovery Today, 25(1), 248–258. https://doi.org/10.1016/j.drudis.2019.10.014
   PubMed Web of Science ®Google Scholar
• Kirchmair, J., Markt, P., Distinto, S., Wolber, G., & Langer, T. (2008). Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection-what can we learn from earlier mistakes?. Journal of Computer-Aided Molecular Design, 22(3–4), 213–228. https://doi.org/10.1007/s10822-007-9163-6
   PubMed Web of Science ®Google Scholar
• Klebe, G., Abraham, U., & Mietzner, T. (1994). Molecular similarity indices in a Comparative Analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. Journal of Medicinal Chemistry, 37(24), 4130–4146. https://doi.org/10.1021/jm00050a010
   PubMed Web of Science ®Google Scholar
• Kok-Yong, S., & Lawrence, L. (2015). Drug distribution and drug elimination. In Basic pharmacokinetic concepts and some clinical applications. InTech. https://doi.org/10.5772/59929
   Google Scholar
• Kontoyianni, M., McClellan, L. M., & Sokol, G. S. (2004). Evaluation of docking performance: Comparative data on docking algorithms. Journal of Medicinal Chemistry, 47(3), 558–565. https://doi.org/10.1021/jm0302997
   PubMed Web of Science ®Google Scholar
• Kroemer, R. T., Vulpetti, A., McDonald, J. J., Rohrer, D. C., Trosset, J.-Y., Giordanetto, F., Cotesta, S., McMartin, C., Kihlén, M., & Stouten, P. F. W. (2004). Assessment of docking poses: Interactions-Based Accuracy Classification (IBAC) versus crystal structure deviations. Journal of Chemical Information and Computer Sciences, 44(3), 871–881. https://doi.org/10.1021/ci049970m
   PubMedGoogle Scholar
• Mittal, R. R., Harris, L., McKinnon, R. A., & Sorich, M. J. (2009). Partial charge calculation method affects CoMFA QSAR prediction accuracy. Journal of Chemical Information and Modeling, 49(3), 704–709. https://doi.org/10.1021/ci800390m
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19(14), 1639–1662.
   Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Onodera, K., Satou, K., & Hirota, H. (2007). Evaluations of molecular docking programs for virtual screening. Journal of Chemical Information and Modeling, 47(4), 1609–1618. https://doi.org/10.1021/ci7000378
   PubMed Web of Science ®Google Scholar
• Ouattara, A., & Laurens, M. B. (2015). Vaccines against malaria. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 60(6), 930–936. https://doi.org/10.1093/cid/ciu954
   PubMed Web of Science ®Google Scholar
• Petersen, I., Eastman, R., & Lanzer, M. (2011). Drug-resistant malaria: Molecular mechanisms and implications for public health. FEBS Letters, 585(11), 1551–1562. https://doi.org/10.1016/j.febslet.2011.04.042
   PubMed Web of Science ®Google Scholar
• Politzer, P., Lane, P., Concha, M. C., Ma, Y., & Murray, J. S. (2007). An overview of halogen bonding. Journal of Molecular Modeling, 13(2), 305–311. https://doi.org/10.1007/s00894-006-0154-7
   PubMed Web of Science ®Google Scholar
• Powell, M. J. D. (1977). Restart procedures for the conjugate gradient method. Mathematical Programming, 12(1), 241–254. https://doi.org/10.1007/BF01593790
   Web of Science ®Google Scholar
• Rizwan, H. M., Abbas, H., Sajid, M. S., Maqbool, M., Jones, M. K., Ullah, M. I., & Ijaz, N. (2021). Drug resistance in protozoal infections. In Hafiz Muhammad Rizwan, Haider Abbas, Muhammad Sohail Sajid, Mahvish Maqbool, Malcolm K. Jones (Eds.), Biochemistry of drug resistance (pp. 95–142). https://doi.org/10.1007/978-3-030-76320-6_4
   Google Scholar
• Roy, K. (2007). On some aspects of validation of predictive quantitative structure-activity relationship models. Expert Opinion on Drug Discovery, 2(12), 1567–1577. https://doi.org/10.1517/17460441.2.12.1567
   PubMed Web of Science ®Google Scholar
• Roy, K., & Mitra, I. (2011). On various metrics used for validation of predictive QSAR models with applications in virtual screening and focused library design. Combinatorial Chemistry & High Throughput Screening, 14(6), 450–474. https://doi.org/10.2174/138620711795767893
   PubMed Web of Science ®Google Scholar
• Roy, K., Kar, S., & Das, R. N. (2015). Understanding the basics of QSAR for applications in pharmaceutical sciences and risk assessment. Elsevier Inc. https://doi.org/10.1016/C2014-0-00286-9
   Google Scholar
• Sarvagalla, S., Syed, S. B., & Coumar, M. S. (2019). An overview of computational methods, tools, servers, and databases for drug repurposing. In In silico drug design (pp. 743–780). Elsevier. https://doi.org/10.1016/b978-0-12-816125-8.00025-0
   Google Scholar
• Scholar, E. (2007). Proguanil. In xPharm: The comprehensive pharmacology reference (pp. 1–4). Elsevier Inc. https://doi.org/10.1016/B978-008055232-3.62471-7
   Google Scholar
• Sirawaraporn, W., Sathitkul, T., Sirawaraporn, R., Yuthavong, Y., & Santi, D. V. (1997). Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proceedings of the National Academy of Sciences of the United States of America, 94(4), 1124–1129. https://doi.org/10.1073/pnas.94.4.1124
   PubMed Web of Science ®Google Scholar
• Sondo, P., Derra, K., Lefevre, T., Diallo-Nakanabo, S., Tarnagda, Z., Zampa, O., Kazienga, A., Valea, I., Sorgho, H., Ouedraogo, J. B., Guiguemde, T. R., & Tinto, H. (2019). Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans. Scientific Reports, 9(1), 1–9. https://doi.org/10.1038/s41598-018-36493-y
   PubMedGoogle Scholar
• Spaggiari, G., Cavaliere, F., & Cozzini, P. (2021). The application of in silico methods on Umami taste receptor. In Giulia Spaggiari, Francesca Cavaliere, & Pietro Cozzini (Eds.), Handbook of experimental pharmacology (pp. 1–18). https://doi.org/10.1007/164_2021_515
   Google Scholar
• Vangapandu, S., Jain, M., Kaur, K., Patil, P., Patel, S. R., & Jain, R. (2007). Recent advances in antimalarial drug development. Medicinal Research Reviews, 27(1), 65–107. https://doi.org/10.1002/med.20062
   PubMed Web of Science ®Google Scholar
• Verhaeghe, P., Azas, N., Hutter, S., Castera-Ducros, C., Laget, M., Dumètre, A., Gasquet, M., Reboul, J. P., Rault, S., Rathelot, P., & Vanelle, P. (2009). Synthesis and in vitro antiplasmodial evaluation of 4-anilino-2-trichloromethylquinazolines. Bioorganic & Medicinal Chemistry, 17(13), 4313–4322. https://doi.org/10.1016/j.bmc.2009.05.022
   PubMed Web of Science ®Google Scholar
• Visser, B. J., Vugt, M. v., & Grobusch, M. P. (2014). Malaria: an update on current chemotherapy. Expert Opinion on Pharmacotherapy, 15(15), 2219–2254. https://doi.org/10.1517/14656566.2014.944499
   PubMed Web of Science ®Google Scholar
• WHO. (2020). World Malaria Report 2020. https://www.who.int/docs/default-source/malaria/world-malaria-reports/9789240015791-double-page-view.pdf?sfvrsn=2c24349d_5. Accessed may 19, 2021.
   Google Scholar
• Wold, S., Ruhe, A., Wold, H., & Dunn, Iii, W. J. (1984). The collinearity problem in linear regression. The Partial Least Squares (PLS) approach to generalized inverses. SIAM Journal on Scientific and Statistical Computing, 5(3), 735–743. https://doi.org/10.1137/0905052
   Web of Science ®Google Scholar
• Wolf, M. E., Zhang, B., Turney, J. M., & Schaefer, H. F. (2019). A comparison between hydrogen and halogen bonding: The hypohalous acid-water dimers, HOX⋯H 2 O (X = F, Cl, Br). Physical Chemistry Chemical Physics, 21(11), 6160–6170. https://doi.org/10.1039/C9CP00422J
   PubMed Web of Science ®Google Scholar
• Yuvaniyama, J., Chitnumsub, P., Kamchonwongpaisan, S., Vanichtanankul, J., Sirawaraporn, W., Taylor, P., Walkinshaw, M. D., & Yuthavong, Y. (2003). Insights into antifolate resistance from malarial DHFR-TS structures. Nature Structural Biology, 10(5), 357–365. https://doi.org/10.1038/nsb921
   PubMedGoogle Scholar